N4 PHARMA PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7115 GBX | -5.13% |
|
-11.06% | -16.29% |
| 04-25 | N4 Pharma strikes partnership deal for intracellular delivery | AN |
| 04-23 | N4 Pharma loss widens but "great optimism" remains | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 2.57M | - | - | - | - | - | |
| 723B | ||||||
| 595B | ||||||
| 369B | ||||||
| 332B | ||||||
| 282B |
- Stock Market
- Equities
- ONZ Stock
- Charts N4 Pharma Plc
- Sector Chart
